UK
India's cheap weight-loss drugs could reshape global obesity fight
Around 50 branded generic drugs are expected to enter the market once India’s patent on semaglutide expires on March 20.
Around 50 branded generic drugs are expected to enter the market once India’s patent on semaglutide expires on March 20.
